The Efficacy of Intravenous Pulse in Attaining Remission in Refractory Juvenile Idiopathic Arthritis

Status: Recruiting
Location: See location...
Intervention Type: Drug
Study Type: Interventional
Study Phase: Phase 3
SUMMARY

Interventional phase 3 study aiming to unravel the value of pulse steroids in achieving remission or low disease activity in refractory active JIA

Eligibility
Participation Requirements
Sex: All
Minimum Age: 2
Maximum Age: 18
Healthy Volunteers: f
View:

• Patients still active despite administration o 2 DMARDs

Locations
Other Locations
Egypt
Al-Azhar University
RECRUITING
Cairo
Time Frame
Start Date: 2024-05-01
Estimated Completion Date: 2024-08-31
Participants
Target number of participants: 215
Treatments
Experimental: pulse steroid
108 patients will receive 125 mg solumedrol intravenous pulse for 2 consecutive days plus their concomitant medication.
Placebo_comparator: without pulse
107 patients will not receive any additional medications.
Sponsors
Leads: Sohag University

This content was sourced from clinicaltrials.gov